H.C. Wainwright analyst Raghuram Selvaraju lowered the firm’s price target on Rockwell Medical (RMTI) to $3 from $7 and keeps a Buy rating on the shares. The firm cites the impact of the loss of business from the company’s largest customer on the revenue growth trajectory in the near- and medium-term for the target cut.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RMTI:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue